Rebecca Byam

HCWB

Rebecca Byam serves as Chief Financial Officer at HCW Biologics Inc. (HCWB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

18 trades

$1.44M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$1.44M

Companies Traded

HCWB

Active Period

Jul 2021 – May 2025

18 total trades

Most Recent

Buy HCWB

May 7, 2025 · $220.0K

Rebecca Byam's Insider Trading at HCW Biologics Inc. (HCWB)

Buys

18 · $1.44M

Sells

0 · $0.00

Total Shares Bought

494,658

Total Shares Sold

HCWB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 7, 2025↗	Buy	8,462	$26.00	$220.0K	0
Sep 15, 2023↗	Buy	5,000	$2.10	$10.5K	573,946
Sep 13, 2023↗	Buy	10,000	$2.07	$20.7K	568,946
Sep 8, 2023↗	Buy	10,000	$1.99	$19.9K	558,946
Sep 7, 2023↗	Buy	5,000	$1.95	$9.7K	548,946
Jun 9, 2023↗	Buy	20,000	$2.06	$41.3K	543,946
Jun 8, 2023↗	Buy	24,696	$2.07	$51.0K	523,946
Jun 7, 2023↗	Buy	39,062	$1.74	$68.1K	499,250
May 31, 2023↗	Buy	40,000	$1.64	$65.5K	460,188
May 24, 2023↗	Buy	58,486	$1.56	$91.1K	420,188
Sep 15, 2022↗	Buy	15,000	$2.58	$38.7K	327,952
Sep 14, 2022↗	Buy	30,000	$2.61	$78.4K	312,952
Sep 1, 2022↗	Buy	17,200	$2.55	$43.9K	282,952
Aug 30, 2022↗	Buy	20,000	$2.55	$51.0K	265,752
Aug 26, 2022↗	Buy	90,300	$2.54	$229.7K	245,752
Jun 15, 2022↗	Buy	66,452	$2.42	$160.8K	155,452
Aug 23, 2021↗	Buy	10,000	$4.40	$44.0K	62,000
Jul 23, 2021↗	Buy	25,000	$8.00	$200.0K	52,000